IL6 and atherosclerosis: It was developed to provide a newoption for the anti-inflammatory treatment of atherosclerosis in patients withchronic kidney disease, as increasing data suggest that the pro-inflammatoryeffects of IL-6 can exacerbate atherosclerosis and thrombosis.